ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1409

Subglottic Stenosis: A Unique Inflammatory Disorder

Robert S. Katz1 and Robert Bastian2, 1Rush University Medical Center, Chicago, IL, 2Bastian Voice Institute, Downers Grove, IL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Dyspnea

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster Session II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Inflammatory subglottic stenosis may present with discomfort, stridor, and hoarseness. In these patients granulomatosis with angiitis needs to be ruled out.  

 A diagnosis using direct visualization and biopsy is made during videoendoscopy.  Biopsy is often combined with a dilatation procedure performed in the operating room under general anesthesia. Inflammatory subglottic stenosis appears to always recur after dilatation, but intervals between dilatations may possibly be lengthened due to the use of corticosteroid AND immunosuppressive and biologic response modifier medication.

 Methods: We describe 16 patients with inflammatory subglottic stenosis

Results: The patients were diagnosed and followed in a laryngology office. Mean age 35 (21-63). All patients presented with SOB and stridor. Ten also had nasal symptoms, 2 had  saddle nose deformities. 3 pts were positive for cANCA and 4 had pANCA. The patients did not have symptoms of cutaneous or systemic vasculitis, sinusitis, pulmonary or renal involvement or other features of granulomatosis with polyangiitis.  The patients all had biopsies showing acute and chronic inflammatory changes. Granulomas and vasculitis were not seen. All had dilation procedures. One had a cricotracheal resection. 3 pts had a tracheotomy. In cases of recurrent inflammatory subglottic stenosis, corticosteroids were very helpful in treatment. Five pts were treated with methotrexate, and one with cyclophosphamide. Almost all patients were negative for the presence of cytoplasmic antibodies.

Conclusion: Recurrent inflammatory subglottic stenosis is described in 16 patients.  All experienced shortness of breath and stridor.

Inflammatory subglottic stenosis appears to be a unique entity, not  related to granulomatosis with polyangiitis.

Treatment with corticosteroids was helpful, but did not avoid the eventual need for subsequent dilation. Methotrexate was moderately effective. One patient received cyclophosphamide. The use of TNF blockers as other biologic response modifiers is unknown.


Disclosure: R. S. Katz, None; R. Bastian, None.

To cite this abstract in AMA style:

Katz RS, Bastian R. Subglottic Stenosis: A Unique Inflammatory Disorder [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/subglottic-stenosis-a-unique-inflammatory-disorder/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/subglottic-stenosis-a-unique-inflammatory-disorder/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology